设为首页收藏本站
开启辅助访问 切换到窄版

 找回密码
 To register

QQ登录

只需一步，快速开始

扫一扫，访问微社区

  • ALL
  • Journals
  • Books

派博传思国际中心 »期刊书目

› Journal of SCIE
› HEMATOLOGY(血液学)

1234下一页
返回列表

SCIE期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024/2025影响因子:5.521 (CRIT REV ONCOL HEMAT) (1040-8428). (HEMATOLOGY)(血液学)

[复制链接]
查看: 25759|回复: 35
发表于 2025-3-21 19:04:16 | 显示全部楼层 |阅读模式
期刊全称CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
期刊简称CRIT REV ONCOL HEMAT
影响因子20245.521
视频video
ISSN1040-8428
eISSN1879-0461
出版商ELSEVIER SCIENCE INC
发行地址STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169
学科分类1.Science Citation Index Expanded (SCIE)--Oncology | Hematology; 2.BIOSIS Previews_BIOSIS Citation Index--Oncology | Hematology; 3.BIOSIS Reviews Reports And Meetings--Oncology | Hematology; 4.Current Contents Clinical Medicine--Oncology; 5.Essential Science Indicators--Clinical Medicine;
出版语言English
The information of publication is updating

SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(20 21 REV HIST)影响因子


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(CRIT REV ONCOL HEMAT)影响因子@(血液学)学科排名


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(20 21 REV HIST)总引论文


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(CRIT REV ONCOL HEMAT)总引论文@(血液学)学科排名


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(20 21 REV HIST)影响因子


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(CRIT REV ONCOL HEMAT)总引频次@(血液学)学科排名


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(CRIT REV ONCOL HEMAT)即时影响因子@(血液学)学科排名


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY(CRIT REV ONCOL HEMAT)五年累积影响因子@(血液学)学科排名


单选投票, 共有 1 人参与投票
1.jpg
 

0票 0.00%

Perfect with Aesthetics
2.jpg
 

0票 0.00%

Better Implies Difficulty
3.jpg
 

0票 0.00%

Good and Satisfactory
4.jpg
 

1票 100.00%

Adverse Performance
5.jpg
 

0票 0.00%

Disdainful Garbage
您所在的用户组没有投票权限
purulent
回复

举报

发表于 2025-3-22 00:08:51 | 显示全部楼层
Submitted on: 01 January 2025. Revised on: 27 April 2025. Accepted on: 25 June 2025. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
GUISE
回复

举报

发表于 2025-3-22 02:50:14 | 显示全部楼层
Submitted on: 10 September 2002. Revised on: 07 October 2002. Accepted on: 28 October 2002. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
RAG
回复

举报

发表于 2025-3-22 05:27:23 | 显示全部楼层
META
回复

举报

发表于 2025-3-22 09:05:59 | 显示全部楼层
Submitted on: 28 March 2021. Revised on: 06 June 2021. Accepted on: 19 June 2021. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
思考
回复

举报

发表于 2025-3-22 16:42:33 | 显示全部楼层
intangibility
回复

举报

发表于 2025-3-22 19:05:21 | 显示全部楼层
Aerate
回复

举报

发表于 2025-3-22 23:03:52 | 显示全部楼层
回复

举报

发表于 2025-3-23 05:25:28 | 显示全部楼层
Submitted on: 21 January 2005. Revised on: 15 February 2005. Accepted on: 06 April 2005. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
绝缘
回复

举报

发表于 2025-3-23 05:42:39 | 显示全部楼层
Submitted on: 08 July 2015. Revised on: 11 September 2015. Accepted on: 02 October 2015. ___________________CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
BLAZE
回复

举报

下一页 »
1234下一页
返回列表
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 11:50
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表